These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3590111)

  • 1. Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.
    Reber P; Furlan M; Beck EA; Barbui T
    Thromb Res; 1987 Apr; 46(1):163-7. PubMed ID: 3590111
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin.
    Laugen RH; Bithell TC
    Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
    Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
    Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M; Leupin L; Biasiutti FD; Lämmle B
    Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary dysfibrinogenemia--the first 25 years.
    Bithell TC
    Acta Haematol; 1984; 71(3):145-9. PubMed ID: 6424378
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital dysfibrinogenemia: fibrinogen Lille.
    Denninger MH; Finlayson JS; Reamer LA; Parquet-Gernez A; Goudemand M; Menache D
    Thromb Res; 1978 Sep; 13(3):453-66. PubMed ID: 741439
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of inherited dysfibrinogenaemia and protein C deficiency in two unrelated families.
    Gandrille S; Priollet P; Capron L; Roncato M; Fiessinger JN; Aiach M
    Br J Haematol; 1988 Mar; 68(3):329-37. PubMed ID: 3355791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins.
    Doolittle RF
    Adv Exp Med Biol; 1990; 281():25-37. PubMed ID: 2102616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.